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he Pulse of Cardiology
uo Vadis?*
ichael F. O’Rourke, MD, DSC,
hristopher S. Hayward, MBBS, MD
ydney, Australia
he value of new analytical techniques is increasingly
ecognized in cardiology. These may be statistical (1) or
athematical (2) and permit new information to be ex-
racted from data, which are readily available or can be
ollected easily. An example is analysis of the pulse wave-
orm, which can easily be measured by tonometry at the
rist or in the neck (3). At present, the pulse is only utilized
or measurement of heart rate, or through estimation of its
eak and nadir as systolic and diastolic blood pressure,
espectively. Yet, the pulse is known to contain key infor-
ation, and its waveform was first used to identify elevated
lood pressure and to chart the natural history of essential
ypertension well over a century ago (4) and to identify the
herapeutic effect of glyceryl trinitrate (5)—all well before
linical introduction of the now ubiquitous brachial cuff.
See pages 695 and 705
ew pulse wave developments in the understanding of
ging, heart failure, and hypertension have appeared in the
ournal recently, with 2 articles in the current issue. The first
6) deals with arterial wave reflection and genetic influences
n women, the second with the effects of drugs and heart
ate on central systolic arterial pressure and its derivation
rom brachial pulse waves (7). For clinicians to benefit from
he studies, it is desirable to provide background and to
ummarize development of this field of pulse waveform
nalysis.
he Brachial Cuff and Brachial Pressures
he cuff sphygmomanometer was introduced by Riva Rocci
n 1896 to measure systolic pressure by palpation, with the
uscultatory Korotkov method introduced in 1905 for mea-
urement of diastolic pressure (8,9). Neither method was or
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the University of New South Wales/Victor Chang Cardiac Research
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ounding director of Atcor Medical Pty. Limited (manufacturer of systems for
nalyzing the arterial pulse).ould be calibrated against intra-arterial pressure at the
ime, and it was only after 50 years that studies showed that
he Riva Rocci and Korotkov techniques usually underesti-
ated brachial systolic pressure and overestimated diastolic
ressure, even when phase 5 (sound disappearance) was used
10). Nonetheless, sphygmomanometry, due to its simplicity
f use and widespread application, continues to provide
trong prognostic information. Using the Framingham
tudy data, diastolic pressure was shown to be the best
redictor of events under age 40 years, systolic the best
redictor over age 40 years, and pulse pressure (systolic 
iastolic) the best predictor over age 60 years (11–13).
hese views have been supported by modern data, although
hey challenged the seemingly irrefutable older data on 1
illion subjects who were followed up in decades past (14).
rterial Tonometry and Arterial Pressure Waves
he first sphygmograms, used to record the pulse waveform
y Mahomed and Marey (4,8,15), were mechanical devices
nd difficult to use (9,10). It is small wonder that they were
wept aside by the brachial pressure cuff in the early 1900s.
ince then, arterial applanation tonometry has become
idely used and shown to be accurate in recording the
hape of the pressure wave in different arteries (3) and the
urther changes that occur with aging and with drug
herapy. Studies with arterial models and in patients at
ardiac catheterization showed that the upper limb arteries
between ascending aorta and wrist) could be characterized
n the frequency domain by a transfer function, which was
imilar in adult humans and changed little with aging,
isease, and drugs (16–18). This transfer function permit-
ed the central aortic pressure waveform to be generated
rom the radial pulse waveform (10,16). When calibrated to
he sphygmomanometer for systolic and diastolic pressure,
ne could calculate the central aortic systolic, diastolic, and
ulse pressure (19). In large studies, central pressures were
ound to be more robust than brachial pressures at predict-
ng events in epidemiological and drug trials (20,21), her-
lding the next era of blood pressure management.
Factors that affect the relationship between the peripheral
rterial pressure waveform and the central waveform are
ecoming more widely appreciated both in healthy (6) and
n hypertensive populations (7). In studies of central pres-
ure, interest has focused on the waveform and the factors
hat influence this (10,22). The most obvious factor is
entricular ejection, which creates the initial part of the
ave; this travels over the arterial tree to the peripheral
rterioles, where there is an abrupt increase in impedance at
he arteriolar level. Steady flow is generated in the arterioles
nd the wave is reflected, and travels back to the heart as an
cho of the initial wave. This reflected wave is superimposed
n the initial wave; thus, the pressure wave in an artery
haracteristically has 2 peaks (whereas ascending aortic flow
as just 1 peak) (10,22). In young adults, the reflected wave
eturns to the heart at the end of systole, and boosts
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August 18, 2009:714–7 The Pulse of Cardiologyoronary flow throughout diastole. In older persons, as a
onsequence of arterial stiffening, the wave travels faster and
eturns earlier and forms a secondary wave during late
ystole. The ill effects of aging can be seen as augmentation
f late systolic pressure, as well as increase in amplitude of
he primary wave (23).
In clinical studies, the influence of proximal aortic stiff-
ess can be gauged by the amplitude of the initial wave in
he aortic pulse, and the ill effect of wave reflection can be
auged by the degree of pressure augmentation (23). Pres-
ure augmentation is a manifestation of the ill effect of wave
eflection increasing pulsatile afterload, as previously char-
cterized by vascular impedance (24). Basic principles of
rterial hemodynamics are provided in textbooks and re-
iews (8,10,19,22,23). Pulse waveforms can be analyzed in
he frequency and the time domains, and must provide
dentical information on wave travel and reflection. Yet,
here is considerable controversy in the field, especially with
espect to aging changes, and the relevance of wave reflec-
ion and its modification by drugs. New outcome informa-
ion is beginning to emerge from the Framingham study,
hich has been measuring arterial pulse waves in its present
ohort for over a decade (25,26).
eritability and Wave Reflection
he first paper in this issue of the Journal (6) uses
easurements of ascending aortic pressure waveforms,
ith the SphygmoCor device (AtCor Medical, Sydney,
ustralia), together with carotid-femoral (“aortic”) pulse
ave velocity and measurement of proximal aortic, ab-
ominal aortic, and femoral artery diameter in a large
roup of women from the Twins UK registry. Cecelja et
l. (6) used amplitude of the primary wave (P1) to
epresent pressure generated by ventricular ejection and
mplitude of the central augmented wave (cAP) as an
ndication of wave reflection, and expressed augmenta-
ion index (AIx) as AP/(P1  AP). As had others (27),
hey found cAP and AIx to be highly hereditable. They
ound a close relationship between P1 and aortic pulse
ave velocity, as one would expect. They also demon-
trated a strong inverse relationship between arterial
apering with wave reflection, consistent with basic hemo-
ynamic theory of differences in regional vascular imped-
nce. Height was not included in the multiple regression
nalysis, despite its well-known relationship with augmen-
ation and with wave reflection (27,28). The very strong
eritability previously shown for height (27) may have gone
long way to explaining the heritability demonstrated in the
urrent study.
Study results were seen by authors to differ from those
eported by Mitchell et al. (25) for the Framingham results
nd Segers et al. (29) for the large European Asklepios
ohort. On the basis of their work, Mitchell et al. (25) have
rgued that change in aortic stiffness rather than of wave
eflection is responsible for change in central aortic pressure (ith aging. Others, including ourselves (30,31), see this
ifferently, with wave reflection predominant, but being
anifest as a boost to late systolic pressure or reduction in
ate systolic flow in older subjects (32). This area is complex,
ut should be resolved by longitudinal data, which will come
rom the Framingham and Asklepios investigators.
eart Rate and Wave Reflection
n this issue of the Journal, Williams and Lacy (7) expand
heir analysis of the CAFE (Conduit Artery Function
valuation) study (21) in order to examine how use of
tenolol led to a higher central systolic pressure than did
mlodipine for the same change in systolic brachial pressure.
he CAFE study was a substudy of the ASCOT (Anglo-
candinavian Cardiac Outcomes Trial) study (33), which
howed superiority of amlodipine over atenolol in reducing
ardiovascular events. Results of the CAFE study explained
enefit on the basis of greater reduction in central than
rachial systolic pressure with amlodipine. Williams and
acy (7) sought to find whether the lesser benefit of atenolol
n the CAFE study came directly from the drug, or as a
onsequence of reduction in heart rate. Their conclusion
as that reduction of heart rate was the major contributor to
he difference seen in the CAFE study. The difference
etween brachial and aortic systolic was found to vary
etween 4 mm Hg at a heart rate of 45 beats/min and 20
m Hg at a heart rate of 110 beats/min. The difference can
e expressed as lesser amplification at low heart rates, and
reater amplification at higher heart rates.
Results are convincing, but not entirely surprising. Data
ere plotted over the range of 45 to 110 beats/min or 0.75
o 1.9 Hz. The transfer function used in the same Sphyg-
oCor device used by Cecelja et al. (6) shows substantial
mplification between these frequencies (34), and substan-
ially more between 1.5 and 3.0 Hz, which corresponds to
he second harmonic of the pressure wave. Amplification is
t its peak (of 2.5- to 3-fold) at around 4 Hz. Further,
aylor (35) emphasized that wave reflection depends on
requency, as a consequence of physical dispersion of pe-
ipheral reflection sites, and varies between around 80% at
ery low frequencies (1 Hz in man) to zero at higher
requencies (10 Hz). This was demonstrated in dogs by
lexander et al. (36) in 1989. Amplification of the com-
ound wave is shown to vary substantially also with heart
ate (37), with values similar to those reported by Williams
nd Lacy (7). Reading their report, skeptics might be
empted to say that the major disadvantage of atenolol is
hat it reduced heart rate, and that if heart rate remained
nchanged, amlodipine would have shown no advantage.
ut amlodipine and other dihydropyridines do reduce wave
eflection, and this is manifest as a reduction in augmenta-
ion index and augmentation of the aortic pressure wave,
nd is seen independently of heart rate when ascending
ortic impedance is displayed in the frequency domain
38,39). The studies by Ting et al. (40) quoted by authors
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The Pulse of Cardiology August 18, 2009:714–7howed such behaviors for impedance with nifedipine,
itroprusside, and angiotensin-converting enzyme inhibi-
ors, but not diuretics (41), without a change in heart rate.
he authors suggested that low heart rate may be disadvan-
ageous, and were hard pressed to explain benefits of
radycardia in trained athletes at rest. Trained athletes
sually have lower wave reflection as a consequence of
reater peripheral arterial vasodilation, attributed to im-
roved endothelial function (10,42). It is well known that
eart rate is a risk factor for cardiovascular disease (43)—so
he general proposition does not hold.
The authors also discuss the lesser value of beta-blocking
rugs, particularly those which reduce heart rate, on stroke,
nd attribute this to greater wave reflection. We see this as
uite probable, and based on the view of “pulse wave
ncephalopathy” when the pulsatile component of flow is
ncreased in the cerebral microvasculature (44,45). Flow
ulsations are increased in the internal carotid artery when
ave reflection is increased at slow heart rates (46), correlate
ith increased pressure augmentation in this vessel (45),
nd can be reduced by an arterial dilating drug (47). The
ossibility that beta-blockers enhance wave reflection (i.e.,
he reflection coefficient) due to reflex vasoconstriction is
ot really discussed. This raises the possibility that vasodi-
ating beta-blockers may not have the same effects. Simi-
arly, sinus node inhibitors devoid of vascular activity such as
vabradine may not have such an adverse effect. It should be
e-emphasized that the population under study is a hyper-
ensive cohort, and that beta-blockers remain one of the
ornerstones of therapy for chronic systolic heart failure and
n the early post-infarction population.
So where is this field heading? It stands to reason that
he 2 techniques used clinically in the past (study of the
ulse and studies from the cuff) can be combined to better
haracterize left ventricular load and to understand the
ffects of drugs and of disease. We have been confused
nd misled in the past by overinterpretation of brachial
iastolic pressure as the “sine qua non” for definition of
ypertension. We have been misled by systolic brachial
ressure, finding that this can be 20 mm Hg or more (80
m Hg during exercise) (10) greater than aortic and left
entricular systolic pressure. The least accurate part of
stimating central aortic pressure is the measurement of
uff pressure—particularly diastolic pressure (48), rather
han measurement of the pulse by applanation tonometry
t the wrist— or even in the neck from the carotid
rteries. Further studies may show that measures that do
ot depend on the cuff, such as AIx or amplification
etween aorta and radial artery, may be superior to
easurements that depend on cuff values. This has
lready been suggested in small studies for regression of
eft ventricular hypertrophy in hypertension (49) and for
evelopment of cerebral lacunar infarcts (45,46).
The ubiquitous brachial cuff sphygmomanometer has
hanged only cosmetically since its introduction over a
entury ago, in the era of the Wright Brothers’ conquest ofhe skies. It needs be supplemented, and better use of the
rterial pulse is a logical path. This view endorses that of
rederick Mahomed when, as a 23-year-old medical stu-
ent, he addressed a meeting at Guy’s Hospital London and
aid, “The pulse ranks first among our guides; no surgeon
an despise its counsel, no physician shut his ears to its
ppeal. Since then the information the pulse affords is of so
reat importance, and so often consulted, surely it must be
o our advantage to appreciate fully all it tells us, and to draw
rom it all that it is capable of imparting.”
eprint requests and correspondence: Dr. Michael F. O’Rourke,
uite 810, St. Vincent’s Clinic, 438 Victoria Street, Darlinghurst,
ydney, NSW 2010, Australia. E-mail: m.orourke@unsw.
du.au.
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